Vivli to launch a portal for sharing data from COVID-19 trials
- Details
- Category: Research
In a visible sign of data sharing leadership, Vivli, the Center for Clinical Research Data has committed to serving the open science community through the launch of a COVID-19 portal for sharing of completed interventional treatment trial data. All member and user fees would be waived for sharing and access.
Understanding how COVID-19 affects children vital to slowing pandemic
- Details
- Category: Research
Though COVID-19 so far appears to be largely sparing children, researchers are cautioning that it is critical to understand how the virus affects kids to model the pandemic accurately, limit the disease's spread and ensure the youngest patients get the care they need.
The COVID-19 coronavirus epidemic has a natural origin
- Details
- Category: Research
The novel SARS-CoV-2 coronavirus that emerged in the city of Wuhan, China, last year and has since caused a large scale COVID-19 epidemic and spread to more than 70 other countries is the product of natural evolution, according to findings published today in the journal Nature Medicine.
COVID-19: The immune system can fight back
- Details
- Category: Research
Melbourne researchers have mapped immune responses from one of Australia's first novel coronavirus (COVID-19) patients, showing the body's ability to fight the virus and recover from the infection.
Researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) - a joint venture between the University of Melbourne and the Royal Melbourne hospital
New kind of CRISPR technology to target RNA, including RNA viruses like coronavirus
- Details
- Category: Research
CRISPR-based genetic screens have helped scientists identify genes that are key players in sickle-cell anemia, cancer immunotherapy, lung cancer metastasis, and many other diseases. However, these genetic screens are limited in scope: They can only edit or target DNA. For many regions of the human genome, targeting DNA may not be effective, and other organisms, such as RNA viruses like coronavirus or flu, cannot be targeted at all with existing DNA-targeting CRISPR screens.
A world premiere from Erasmus MC and Utrecht University: they found an antibody against COVID-19
- Details
- Category: Research
Since Thursday evening, the article by a team of ten scientists has been online on BioRxiv - a website where biologists can publish their research before it will be assessed by the prestigious journal Nature. In the summary, the scientists describe an antibody to SARS2, the coronavirus causing the current pandemic (COVID-19). The antibody can help detect and prevent this type of corona infection.
Statins starve cancer cells to death
- Details
- Category: Research
More than 35 million Americans take statin drugs daily to lower their blood cholesterol levels. Now, in experiments with human cells in the laboratory, researchers at Johns Hopkins Medicine have added to growing evidence that the ubiquitous drug may kill cancer cells and have uncovered clues to how they do it.
More Pharma News ...
- Special report highlights potential therapeutic agents, vaccines for COVID-19
- Low-dose aspirin linked to reduced liver cancer risk
- Immune cells against Alzheimer's?
- Gut bacteria can penetrate tumors and aid cancer therapy
- Individual response to COVID-19 'as important' as government action
- Preventing spread of SARS coronavirus-2 in humans
- Newly discovered brain response to obesity drug may inform future treatments